Biotechnology Blueprint Medicines Provides 2023 Portfolio Goals to Achieve Precision at Scale January 5, 2023
Biotechnology Strength Seen in Fate Therapeutics (FATE): Can Its 9.3% Jump Turn into More Strength? January 5, 2023
Biotechnology Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer January 5, 2023
Health SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, MLVF, TCFC January 5, 2023